Crescita Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	8.31	9.27	9.39	8.24	11.33	14.28
Short-Term Investments	-	0	0	0.07	0.08	0.06
Cash & Short-Term Investments	8.31	9.28	9.39	8.31	11.41	14.34
Cash Growth	-1.54%	-1.19%	12.97%	-27.17%	-20.44%	53.74%
Accounts Receivable	1.91	1.58	2.75	6.14	3.6	1.22
Other Receivables	-	0.13	0.02	0.1	0.15	0.2
Receivables	1.91	1.72	2.78	6.24	3.75	1.42
Inventory	5.36	4.05	6.13	5.65	4.39	3.46
Prepaid Expenses	-	0.26	0.2	0.32	0.54	0.24
Other Current Assets	0.4	-	-	-	-	-
Total Current Assets	15.99	15.3	18.49	20.52	20.09	19.45
Property, Plant & Equipment	2.12	2.42	1.85	2.31	2.58	0.79
Long-Term Investments	-	0.31	0.36	0.34	0.34	-
Other Intangible Assets	1.63	1.74	1.99	2.87	3.74	4.61
Long-Term Accounts Receivable	1.42	1.39	1.48	1.57	1.66	1.98
Long-Term Deferred Tax Assets	-	-	-	0.46	-	-
Total Assets	21.46	21.78	24.6	28.48	28.92	26.83
Accounts Payable	4.59	5	4.33	5.59	5.33	4.27
Current Portion of Long-Term Debt	-	-	-	-	0.98	-
Current Portion of Leases	0.48	0.47	0.44	0.41	0.37	0.3
Other Current Liabilities	0.05	0.05	0.1	0.06	0.06	0.05
Total Current Liabilities	5.12	5.52	4.86	6.06	6.73	4.62
Long-Term Debt	-	-	-	-	-	0.93
Long-Term Leases	-	0.37	0.82	1.21	1.53	-
Other Long-Term Liabilities	0.08	0.07	0.1	0.12	0.15	0.15
Total Liabilities	5.2	5.95	5.78	7.39	8.4	5.7
Common Stock	51.49	52.7	54.34	56.3	58.08	58.18
Additional Paid-In Capital	8.4	7.37	5.96	4.27	2.77	2.27
Retained Earnings	-44.73	-45.35	-42.6	-40.61	-41.48	-40.37
Comprehensive Income & Other	1.1	1.11	1.12	1.13	1.15	1.05
Shareholders' Equity	16.26	15.83	18.82	21.1	20.53	21.13
Total Liabilities & Equity	21.46	21.78	24.6	28.48	28.92	26.83
Total Debt	0.48	0.83	1.25	1.61	2.87	1.23
Net Cash (Debt)	7.82	8.44	8.13	6.7	8.54	13.11
Net Cash Growth	4.15%	3.79%	21.46%	-21.60%	-34.85%	68.51%
Net Cash Per Share	0.41	0.44	0.40	0.32	0.41	0.63
Filing Date Shares Outstanding	18.61	19.01	19.54	20.33	20.9	20.62
Total Common Shares Outstanding	18.61	19.08	19.96	20.33	20.98	20.65
Working Capital	10.86	9.79	13.62	14.46	13.37	14.84
Book Value Per Share	0.87	0.83	0.94	1.04	0.98	1.02
Tangible Book Value	14.63	14.09	16.83	18.23	16.79	16.52
Tangible Book Value Per Share	0.79	0.74	0.84	0.90	0.80	0.80
Machinery	-	3.59	2.68	2.56	2.32	1.97
Leasehold Improvements	-	0.62	0.62	0.62	0.62	0.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.